The China International Medical Equipment Fair (CMEF) is one of the largest and most influential events in the global medical device industry. Held biannually, it brings together healthcare leaders, medical innovators, and technology pioneers from around the world. The 2025 Spring Edition, held in Shanghai, provided a key platform for exploring emerging medical trends and showcasing next-generation healthcare solutions. This year from April 8-11, Vinno took the stage to share its vision for the future of medical imaging and diagnostics—highlighting a new generation of cutting-edge ultrasound technologies and products.
On the opening day, Vinno Co-founder Tian Yuan engaged with dozens of media outlets at the company’s booth, sharing her insights into Vinno’s advancements in imaging technologies in the digital era. She also introduced the company’s latest research breakthroughs—most notably, the Ultra-resolution Microscopy (URM) technology, which emerged as a key highlight of the showcase with the latest flagship ultrasound machine Ultimus 9.
URM: Powering the Next-Level Evolution of Medical Imaging
The human body is interlaced with a vascular network spanning over 100,000 kilometers, where microvessels—often measuring less than 100 microns in diameter—play a critical role in the early diagnosis and classification of tumors and other diseases. However, traditional imaging technologies, limited by a resolution ceiling of over 200 μm and inadequate dynamic capture, have long struggled to detect these subtle early indicators. Vinno’s Ultra-resolution Microscopy (URM) breaks through these limitations with unprecedented 20 μm resolution, enabling real-time visualization and quantification of microvessels, microcirculation, and flow dynamics. This breakthrough ushers medical imaging into a new era of super-evolution, advancing the frontier of clinical diagnostics and research.
Ongoing technological innovation and scientific exploration are continuously paving the way toward a healthier future. Vinno has established research collaborations with over 100 hospitals across China, including prestigious institutions such as Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, the General Hospital of the People's Liberation Army, and Peking University Third Hospital. These partnerships focus on nationwide, multi-center clinical studies in areas such as breast cancer, thyroid disorders, lymph node evaluation, and bladder cancer. At the micron scale, Vinno is committed to unlocking new frontiers in life sciences and finding solutions to some of the most complex challenges in modern medicine.
Driving the Full Potential of Precision Diagnosis
Healthcare is entering a new phase powered by intelligent technology. Vinno’s smart ultrasound products are designed to support more efficient, accurate, and collaborative diagnostics. With advanced algorithms that help identify lesions and detect potential risks, these systems go beyond traditional imaging—supporting doctors in making faster and more informed decisions.
Vinno’s smart ultrasound systems are equipped with the VAid series of automated detection and analysis technologies, supporting more accurate diagnosis of thyroid, breast, and liver diseases. For liver conditions, the system can automatically detect lesions, analyze their size and shape, and provide diagnostic references for various types of liver abnormalities, including space-occupying lesions, hepatic hemangioma, liver cancer, and fatty liver. This intelligent diagnostic support helps build a comprehensive screening-to-diagnosis workflow. These clinically driven innovations extend access to quality healthcare and promote collaboration between public and private medical systems—contributing to earlier detection, timely treatment, and more precise intervention for common diseases.
Supporting Safe and Efficient Respiratory Care
Medical technology is not only advancing the frontiers of science but also addressing everyday needs—right down to every breath we take. At CMEF 2025, Vinno unveiled a new direction in respiratory health with the debut of its Stream series of sleep apnea machines. These CPAP (Continuous Positive Airway Pressure) devices are designed for home use to treat sleep-disordered breathing, especially obstructive sleep apnea (OSA)—a silent threat to health.
The Vinno Stream series features FOAMLESS noise-reduction technology, eliminating the risks associated with degrading foam materials in traditional devices. With ultra-quiet performance at just 27 dBA, it creates a peaceful and restful sleep environment. In terms of user experience, the system offers six ventilation modes to meet the needs of various OSA patients. Its event-driven pressure control adjusts airflow gently and intelligently. It also includes smart sleep onset detection with automatic pressure ramp-up delay to reduce discomfort, delivering a more personalized and comfortable treatment experience.
In addition, Vinno continues to expand its presence in diverse clinical scenarios with a wide range of ultrasound solutions, including handheld, portable, and remote ultrasound systems. These innovations are designed to bring quality imaging closer to patients and enhance accessibility across different healthcare settings.
At the heart of medical innovation lies a deep respect for life. Vinno is committed to transforming scientific ideals into tangible advances in care—illuminating the path from technological progress to real-life impact. We look forward to collaborating with more healthcare professionals and researchers to help life thrive with strength and dignity.
